Vaccine against mycobacterial infections

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/10 (2006.01) A61K 31/7088 (2006.01) A61K 35/28 (2006.01) A61K 39/04 (2006.01) A61P 31/06 (2006.01) C12N 15/31 (2006.01)

Patent

CA 2190515

A naked nucleic acid construct comprising a coding sequence which encodes a mycobacterial stress protein or proline-rich antigen or an antigenically effective fragment thereof operably linked to a promoter capable of expressing the said coding sequence in a mammalian host cell is useful as a vaccine against a mycobacterial infection such as tuberculosis and leprosy.

Produit de recombinaison nu d'acide nucléique comprenant une séquence codante codant une protéine de stress mycobactérienne ou un antigène riche en proline ou un de ses fragments antigéniquement efficace lié à un promoteur capable d'exprimer ladite séquence codante chez une cellule hôte de mammifère. Ledit produit de recombinaison est efficace en tant que vaccin contre une infection mycobactérienne, telle que la tuberculose et la lèpre.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vaccine against mycobacterial infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine against mycobacterial infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine against mycobacterial infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1599811

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.